The Buy New Zealand Made Campaign has licensed the first medicinal cannabis manufacturer to use the New Zealand Grown logo.

The Buy New Zealand Made Campaign has licensed the first medicinal cannabis manufacturer to use the New Zealand Grown logo.

Auckland-based Helius Therapeutics has been approved to carry the New Zealand Made Kiwi logo on medicinal products derived from cannabis grown in New Zealand.

New Zealand-grown products can gain approval to carry the Kiwi logo as well as New Zealand-manufactured products licensed by the Buy NZ Made Campaign.

The Buy New Zealand Made Campaign will allow Helius to use the Kiwi logo to promote its cannabis products in export markets and also in New Zealand once legislation permits.

READ MORE:

* How I accidentally became a drug smuggler

* Medicinal cannabis cultivation licence issued to East Coast company for research purposes

* Medical cannabis is all the rage - but that's exactly what people in pain need

"New Zealand Grown is already a trusted logo for consumers of plant based extracts with medicinal properties," Buy New Zealand Made executive director Ryan Jennings said.

"We look forward to seeing Helius Therapeutics differentiate their product in market through the New Zealand Grown labelling."

GRANT MATTHEW/STUFF The global cannabis market is estimated to reach $200 billion by 2025.

​Helius Therapeutics says the New Zealand Grown license is a powerful marketing tool that will give consumers confidence that its products are of authentic Kiwi origin.

Executive director and co-founder of Helius Therapeutics Paul Manning said, "We have a vertically integrated business model for growing, developing and manufacturing medicinal cannabis products in New Zealand. From here, we will export premium, locally-made products to the world.

"Our marketing strategy will strongly leverage New Zealand provenance. Our products will carry the New Zealand Grown logo so they can be clearly identified as containing cannabis cultivated and manufactured in New Zealand.

"The global cannabis market is estimated to reach $200 billion by 2025. There is enormous value in being New Zealand-grown and this will be a key point of difference for Helius products competing on the world stage."

Helius completed a $15 million capital raise earlier this year and is building a facility in Auckland with over 20,000 square metres of cultivation space, an integrated extraction site, an advanced cannabinoid research laboratory and manufacturing operations.